Search research articles
Contact Us
Filters
Showing results (301-310 of 754) with videos related to
Page
of 76
Sort By:
Archives of Neurology
|
August 26, 1998
Pharmacological therapy in progressive supranuclear palsy
K Kompoliti, C G Goetz, I Litvan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2009
Teaching program for the Unified Dyskinesia Rating Scale
Christopher G Goetz, John G Nutt, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devices
K Kompoliti, C G Goetz, S Leurgans, et al.
Journal of Parkinson'S Disease
|
March 12, 2014
Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example
Barbara C Tilley, Nancy R LaPelle, Christopher G Goetz, et al.
Movement Disorders Clinical Practice
|
October 9, 2024
Examining Agreement in Psychotic Symptom Assessment: Insights from Parkinson's Disease Dementia Dyads
Blake Beehler, Michelle H S Tosin, Glenn T Stebbins, et al.
Drug and Alcohol Dependence
|
December 28, 2020
Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey
Jeremy D Kidd, Teddy G Goetz, Eileen A Shea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2013
I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging
Christopher G Goetz, Christina L Vaughan, Jennifer G Goldman, et al.
Cell Adhesion & Migration
|
August 28, 2015
Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?
Ana Sofia Azevedo, Gautier Follain, Shankar Patthabhiraman, et al.
Life Sciences
|
April 9, 1984
Neuroleptic-induced dopamine hyposensitivity
C G Goetz, P M Carvey, C M Tanner, et al.
Advances in Neurology
|
January 1, 1986
Drug-induced myoclonus
H L Klawans, P M Carvey, C M Tanner, et al.
Page
of 76
Search research articles
Search
Showing results (301-310 of 754) with videos related to
Sort By:
Page
of 76
Archives of Neurology
|
August 26, 1998
Pharmacological therapy in progressive supranuclear palsy
K Kompoliti, C G Goetz, I Litvan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2009
Teaching program for the Unified Dyskinesia Rating Scale
Christopher G Goetz, John G Nutt, Glenn T Stebbins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
"On" freezing in Parkinson's disease: resistance to visual cue walking devices
K Kompoliti, C G Goetz, S Leurgans, et al.
Journal of Parkinson'S Disease
|
March 12, 2014
Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example
Barbara C Tilley, Nancy R LaPelle, Christopher G Goetz, et al.
Movement Disorders Clinical Practice
|
October 9, 2024
Examining Agreement in Psychotic Symptom Assessment: Insights from Parkinson's Disease Dementia Dyads
Blake Beehler, Michelle H S Tosin, Glenn T Stebbins, et al.
Drug and Alcohol Dependence
|
December 28, 2020
Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey
Jeremy D Kidd, Teddy G Goetz, Eileen A Shea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 12, 2013
I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging
Christopher G Goetz, Christina L Vaughan, Jennifer G Goldman, et al.
Cell Adhesion & Migration
|
August 28, 2015
Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?
Ana Sofia Azevedo, Gautier Follain, Shankar Patthabhiraman, et al.
Life Sciences
|
April 9, 1984
Neuroleptic-induced dopamine hyposensitivity
C G Goetz, P M Carvey, C M Tanner, et al.
Advances in Neurology
|
January 1, 1986
Drug-induced myoclonus
H L Klawans, P M Carvey, C M Tanner, et al.
Page
of 76